Cargando…
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
Background: Cefiderocol is a siderophore cephalosporin antibiotic active against Gram-negative bacteria, including extended-spectrum beta-lactamase and carbapenemase-producing strains. The pharmacokinetics of cefiderocol has been studied in healthy subjects and particularly in phase II and III studi...
Autores principales: | Zahr, Noël, Urien, Saik, Llopis, Benoit, Noé, Gaëlle, Tissot, Nadine, Bihan, Kevin, Junot, Helga, Marin, Clémence, Mansour, Bochra, Luyt, Charles-Edouard, Bleibtreu, Alexandre, Funck-Brentano, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784526/ https://www.ncbi.nlm.nih.gov/pubmed/36559279 http://dx.doi.org/10.3390/pharmaceutics14122786 |
Ejemplares similares
-
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021) -
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021) -
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
por: Bleibtreu, Alexandre, et al.
Publicado: (2021) -
Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies
por: Leclerc, Elisabeth, et al.
Publicado: (2018) -
Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth Times
por: Vidal, Pauline, et al.
Publicado: (2022)